Phase I study of pazopanib in combination with interferon alfa in patients with advanced renal cell carcinoma (RCC) and other primary tumors: A Spanish Oncology Genitourinary Group (SOGUG) study.
Xavier Garcia del Muro
Honoraria - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Ignacio Duran
Consultant or Advisory Role - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Jesús García-Donas
Consultant or Advisory Role - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Juan Francisco Rodriguez-Moreno
No relevant relationships to disclose
Marta Gil-Martin
No relevant relationships to disclose